Cargando…

(3aS,7S,9aS,9bR)-3a,6,6,9a-Tetra­methyl-2-oxoperhydro­naphtho[2,1-b]furan-7-yl acetate

The title compound (common name: 3β-acet­oxy-8-epi-sclareolide), C(18)H(28)O(4), is a sclareolide derivative, which was synthesized from 9(11)-en-3β-acet­oxy-8-epi-sclareolide. In the mol­ecular structure, the two six-membered rings display chair conformations and the five-membered ring displays an...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Qing-Chun, Li, Bo-Gang, Xie, Yi-Peng, Yu, Kai-Bei, Zhang, Guo-Lin
Formato: Texto
Lenguaje:English
Publicado: International Union of Crystallography 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2960644/
https://www.ncbi.nlm.nih.gov/pubmed/21201747
http://dx.doi.org/10.1107/S1600536808025737
_version_ 1782188789745057792
author Huang, Qing-Chun
Li, Bo-Gang
Xie, Yi-Peng
Yu, Kai-Bei
Zhang, Guo-Lin
author_facet Huang, Qing-Chun
Li, Bo-Gang
Xie, Yi-Peng
Yu, Kai-Bei
Zhang, Guo-Lin
author_sort Huang, Qing-Chun
collection PubMed
description The title compound (common name: 3β-acet­oxy-8-epi-sclareolide), C(18)H(28)O(4), is a sclareolide derivative, which was synthesized from 9(11)-en-3β-acet­oxy-8-epi-sclareolide. In the mol­ecular structure, the two six-membered rings display chair conformations and the five-membered ring displays an envelope conformation. Weak inter­molecular C—H⋯O hydrogen bonding is present in the crystal structure.
format Text
id pubmed-2960644
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher International Union of Crystallography
record_format MEDLINE/PubMed
spelling pubmed-29606442010-12-30 (3aS,7S,9aS,9bR)-3a,6,6,9a-Tetra­methyl-2-oxoperhydro­naphtho[2,1-b]furan-7-yl acetate Huang, Qing-Chun Li, Bo-Gang Xie, Yi-Peng Yu, Kai-Bei Zhang, Guo-Lin Acta Crystallogr Sect E Struct Rep Online Organic Papers The title compound (common name: 3β-acet­oxy-8-epi-sclareolide), C(18)H(28)O(4), is a sclareolide derivative, which was synthesized from 9(11)-en-3β-acet­oxy-8-epi-sclareolide. In the mol­ecular structure, the two six-membered rings display chair conformations and the five-membered ring displays an envelope conformation. Weak inter­molecular C—H⋯O hydrogen bonding is present in the crystal structure. International Union of Crystallography 2008-08-16 /pmc/articles/PMC2960644/ /pubmed/21201747 http://dx.doi.org/10.1107/S1600536808025737 Text en © Huang et al. 2008 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
spellingShingle Organic Papers
Huang, Qing-Chun
Li, Bo-Gang
Xie, Yi-Peng
Yu, Kai-Bei
Zhang, Guo-Lin
(3aS,7S,9aS,9bR)-3a,6,6,9a-Tetra­methyl-2-oxoperhydro­naphtho[2,1-b]furan-7-yl acetate
title (3aS,7S,9aS,9bR)-3a,6,6,9a-Tetra­methyl-2-oxoperhydro­naphtho[2,1-b]furan-7-yl acetate
title_full (3aS,7S,9aS,9bR)-3a,6,6,9a-Tetra­methyl-2-oxoperhydro­naphtho[2,1-b]furan-7-yl acetate
title_fullStr (3aS,7S,9aS,9bR)-3a,6,6,9a-Tetra­methyl-2-oxoperhydro­naphtho[2,1-b]furan-7-yl acetate
title_full_unstemmed (3aS,7S,9aS,9bR)-3a,6,6,9a-Tetra­methyl-2-oxoperhydro­naphtho[2,1-b]furan-7-yl acetate
title_short (3aS,7S,9aS,9bR)-3a,6,6,9a-Tetra­methyl-2-oxoperhydro­naphtho[2,1-b]furan-7-yl acetate
title_sort (3as,7s,9as,9br)-3a,6,6,9a-tetra­methyl-2-oxoperhydro­naphtho[2,1-b]furan-7-yl acetate
topic Organic Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2960644/
https://www.ncbi.nlm.nih.gov/pubmed/21201747
http://dx.doi.org/10.1107/S1600536808025737
work_keys_str_mv AT huangqingchun 3as7s9as9br3a669atetramethyl2oxoperhydronaphtho21bfuran7ylacetate
AT libogang 3as7s9as9br3a669atetramethyl2oxoperhydronaphtho21bfuran7ylacetate
AT xieyipeng 3as7s9as9br3a669atetramethyl2oxoperhydronaphtho21bfuran7ylacetate
AT yukaibei 3as7s9as9br3a669atetramethyl2oxoperhydronaphtho21bfuran7ylacetate
AT zhangguolin 3as7s9as9br3a669atetramethyl2oxoperhydronaphtho21bfuran7ylacetate